About
Professor João Pedro de Magalhães
Harvard-trained Prof de Magalhães leads the Genomics of Ageing and Rejuvenation Lab at the University of Birmingham. He has published over 100 scientific articles with pioneering work in studying gene networks of aging and in sequencing long-lived species. His research on genetics, aging and longevity has widely been featured in scientific magazines (Science, Nature, Scientific American, New Scientist, etc.).
Prof de Magalhaes has a long-term interest in technological trends and their impact on society with several future scenarios published in magazines and newspapers such as Futures and The Independent. He also advises governments (inc. the UN), nonprofits and industry; he was previously CSO of Swiss-based biotech company Centaura and is currently CSO of US-based biotech YouthBio Therapeutics.
Professor João Pedro de Magalhães
Educational background
Prof de Magalhaes graduated in microbiology, has a PhD in cell senescence, trained in genetics at Harvard Medical School.
Academic experience
Professor at the University of Birmingham with over 100 scientific articles in top journals (Science, Nature- and Cell-family and PNAS).
Prolific writer
In addition to academic publications, Prof de Magalhaes also writes popular science for newspapers and magazines (e.g., The Scientist and The Futurist), and fiction.
Experienced speaker
Over 200 invited talks in international conferences, three TEDx talks, and seminars in various institutions, including companies (e.g., Google's Calico).
Media work
Prof de Magalhaes makes regular media appearances (BBC, CNN, Time magazine, Forbes, the Washington Post, the Financial Times, the New York Times and many others)
